Collaboration to Reduce Disparities in Hypertension

May 10, 2016 updated by: Stephen E. Kimmel, University of Pennsylvania
A large number of African-American and low socioeconomic patients have poorly controlled high blood pressure because of not being able to take their high blood pressure medications. This puts these patients at higher risk of heart and kidney disease, stroke and death. This study is designed to reduce the barriers that prevent patients from taking their high blood pressure medications.

Study Overview

Detailed Description

The objective of this study is to determine the effectiveness and cost-effectiveness of two interventions aimed at reducing barriers to blood pressure (BP) control in an indigent and African-American population. Specifically, we will conduct a randomized controlled trial comparing BP control using either: (1) reimbursing patients for filling prescriptions (reimbursement arm); (2) a computer-based behavioral intervention (behavioral arm); (3) both the reimbursement and behavioral arms (combined arms); or (4) neither.

The ultimate goal of this study is to reduce the incidence of HTN-related CVD among these populations thereby reducing cardiovascular health disparities. Specific aims of the study are to:

  1. test whether receiving money each time the patient fills a prescription for medications improves BP control by a clinically significant amount.

    H1: Reimbursing patients for filling prescriptions will significantly improve BP control.

  2. test whether a computer-based behavioral intervention improves BP control by a clinically significant amount.

    H2: A computer-based behavioral intervention will significantly improve BP control.

  3. test whether the two interventions are more effective in improving BP control than either alone.

    H3: The effect of improving BP control of administering both interventions together will be greater than the sum of the individual effects of each intervention alone.

  4. examine the relative cost effectiveness of reimbursement for filling prescriptions, a computer-based behavioral intervention, and the combination of the two.

H4: Both interventions will be cost-effective relative to other commonly-covered services.

Study Type

Interventional

Enrollment (Actual)

802

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Harrisburg, Pennsylvania, United States, 17101
        • PinnacleHealth Adult Outpatient Clinics
      • Philadelphia, Pennsylvania, United States, 19104
        • Veterans Administration Medical Center
      • Pittsburgh, Pennsylvania, United States, 15240
        • VA Pittsburgh Healthcare System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients of the Philadelphia Veterans Administration Hospital Primary Care Clinic, PinnacleHealth Adult Outpatient Clinics and the VA Pittsburgh Healthcare System who have a diagnosis of hypertension; are currently taking antihypertensive medications; and have elevated blood pressure.

Exclusion Criteria:

  • Under 21 years of age
  • Have a diagnosis of:

    • Atrial fibrillation;
    • Metastatic cancer;
    • End stage renal disease (ESRD) with dialysis;
    • Dementia;
    • New York Heart Association (NYHA) class IV congestive heart failure (CHF);
    • Blind or deaf;
    • Other reason for life expectancy of less than 1 year.
  • Are currently participating in another experimental study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: 1
Control
No intervention
Experimental: 2
Reduction of financial barrier
Copay only
Experimental: 3
Computer Intervention
Computer intervention only
Experimental: 4
Reduction of financial barrier and Computer Intervention
computer intervention & copay

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Blood pressure
Time Frame: 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Blood pressure
Time Frame: 12 months
12 months
Cost
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephen E. Kimmel, MD, MSCE, University of Pennsylvania

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2005

Primary Completion (Actual)

August 1, 2008

Study Completion (Actual)

August 1, 2008

Study Registration Dates

First Submitted

August 19, 2005

First Submitted That Met QC Criteria

August 19, 2005

First Posted (Estimate)

August 22, 2005

Study Record Updates

Last Update Posted (Estimate)

May 12, 2016

Last Update Submitted That Met QC Criteria

May 10, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 707850

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Control

3
Subscribe